Market Overview:
The global peripheral blood market is expected to grow at a CAGR of 7.5% from 2018 to 2030. The growth in the market can be attributed to the increasing prevalence of diseases, rising demand for stem cells and PBMCs, and technological advancements in the field of regenerative medicine. The global peripheral blood market is segmented on the basis of type, application, and region. On the basis of type, the market is segmented into leukopaks, stem cells, PBMCs (peripheral blood mononuclear cells), and others. Leukopaks are further sub-segmented into granulocytes leukopaks and erythrocyte leukopaks. Stem cells are further sub-segmented into adult stem cells and embryonic stem cells. On the basis of application, the market is segmented into disease treatment (cancer therapy & transplantation), research & development (drug discovery & development), and other applications such as diagnostics & prognostics).
Product Definition:
Peripheral Blood is a sample of blood that is taken from a vein in the arm, leg, or hand. It is used to test for certain diseases or to monitor the health of a person receiving treatment.
Leukopak:
Leukopak is a blood substitute which consists of white cells and platelets. It's main function is to replace the damaged blood components in patients suffering from chronic diseases such as leukaemia, cancer, etc. The product also helps in reducing the risk of infection during surgical procedures and improves patient recovery rate. Leukopak has been approved by the U.
Stem Cells:
Stem cells are the body's master healing and regenerative cells. They have the ability to replace any damaged or destroyed tissue in the body. Stem cell therapy has been used for many years for injuries, diseases, and other conditions.
Increasing demand for therapies using autologous.
Application Insights:
The disease treatment segment dominated the global peripheral blood market in 2017. The growing incidences of cancer and other infectious diseases such as HIV are driving the demand for stem cells from donors across the world. In addition, a rise in non-communicable diseases (NCDs) is expected to augment demand for transplantation therapies over the forecast period. For instance, according to WHO, NCDs are responsible for around 60% of deaths globally and this proportion is expected to increase by 2030 due to increasing life expectancy and demographic changes such as more births in developed countries like North America and Europe compared to developing countries like India and China. This trend is expected drive need for peripheral blood stem cell transplants over the forecast period which will further boost industry growth during future years.
Increasing R&D pertaining towards expansion of donor pool including ethnic minorities & unrelated donors & enhancing efficiency rates post-transplantation are some of the key factors that have contributed towards segment growth since past few years.
Regional Analysis:
North America dominated the global market in 2017. The presence of a large number of private and public research laboratories, biotechnology companies, universities and hospitals that are engaged in ongoing R&D activities for the development of stem cell therapies is one major factor contributing to North America’s dominance. Moreover, increasing investments by pharmaceutical companies for the development of innovative medicines using peripheral blood stem cells are also expected to drive growth during the forecast period.
Asia Pacific is anticipated to witness lucrative growth over the forecast period owing to factors such as improving healthcare infrastructure & availability of advanced products & services along with rising patient awareness levels regarding advanced treatment options leading towards better health outcomes at lower costs.
Growth Factors:
- Increasing incidence of cancer and other blood-related disorders is expected to drive the demand for peripheral blood products over the forecast period.
- Rising awareness about peripheral blood donation and its benefits is projected to propel market growth.
- Technological advancements in separation and storage techniques are anticipated to boost the market growth over the next few years.
- Growing number of transplant procedures is likely to create lucrative opportunities for market players in near future.
Scope Of The Report
Report Attributes
Report Details
Report Title
Peripheral Blood Market Research Report
By Type
Leukopak, Stem Cells, PBMCs, Others
By Application
Disease Treatment, Research and Development, Other
By Companies
HemaCare, StemExpress, AllCells, Mozobil
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
235
Number of Tables & Figures
165
Customization Available
Yes, the report can be customized as per your need.
Global Peripheral Blood Market Report Segments:
The global Peripheral Blood market is segmented on the basis of:
Types
Leukopak, Stem Cells, PBMCs, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Disease Treatment, Research and Development, Other
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- HemaCare
- StemExpress
- AllCells
- Mozobil
Highlights of The Peripheral Blood Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Leukopak
- Stem Cells
- PBMCs
- Others
- By Application:
- Disease Treatment
- Research and Development
- Other
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Peripheral Blood Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Peripheral blood is the fluid that circulates in the veins and arteries outside of the body.
Some of the major companies in the peripheral blood market are HemaCare, StemExpress, AllCells, Mozobil.
The peripheral blood market is expected to register a CAGR of 7.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Peripheral Blood Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Peripheral Blood Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Peripheral Blood Market - Supply Chain
4.5. Global Peripheral Blood Market Forecast
4.5.1. Peripheral Blood Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Peripheral Blood Market Size (000 Units) and Y-o-Y Growth
4.5.3. Peripheral Blood Market Absolute $ Opportunity
5. Global Peripheral Blood Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Peripheral Blood Market Size and Volume Forecast by Type
5.3.1. Leukopak
5.3.2. Stem Cells
5.3.3. PBMCs
5.3.4. Others
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Peripheral Blood Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Peripheral Blood Market Size and Volume Forecast by Application
6.3.1. Disease Treatment
6.3.2. Research and Development
6.3.3. Other
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Peripheral Blood Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Peripheral Blood Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Peripheral Blood Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Peripheral Blood Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Peripheral Blood Demand Share Forecast, 2019-2026
9. North America Peripheral Blood Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Peripheral Blood Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Peripheral Blood Market Size and Volume Forecast by Application
9.4.1. Disease Treatment
9.4.2. Research and Development
9.4.3. Other
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Peripheral Blood Market Size and Volume Forecast by Type
9.7.1. Leukopak
9.7.2. Stem Cells
9.7.3. PBMCs
9.7.4. Others
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Peripheral Blood Demand Share Forecast, 2019-2026
10. Latin America Peripheral Blood Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Peripheral Blood Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Peripheral Blood Market Size and Volume Forecast by Application
10.4.1. Disease Treatment
10.4.2. Research and Development
10.4.3. Other
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Peripheral Blood Market Size and Volume Forecast by Type
10.7.1. Leukopak
10.7.2. Stem Cells
10.7.3. PBMCs
10.7.4. Others
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Peripheral Blood Demand Share Forecast, 2019-2026
11. Europe Peripheral Blood Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Peripheral Blood Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Peripheral Blood Market Size and Volume Forecast by Application
11.4.1. Disease Treatment
11.4.2. Research and Development
11.4.3. Other
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Peripheral Blood Market Size and Volume Forecast by Type
11.7.1. Leukopak
11.7.2. Stem Cells
11.7.3. PBMCs
11.7.4. Others
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Peripheral Blood Demand Share, 2019-2026
12. Asia Pacific Peripheral Blood Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Peripheral Blood Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Peripheral Blood Market Size and Volume Forecast by Application
12.4.1. Disease Treatment
12.4.2. Research and Development
12.4.3. Other
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Peripheral Blood Market Size and Volume Forecast by Type
12.7.1. Leukopak
12.7.2. Stem Cells
12.7.3. PBMCs
12.7.4. Others
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Peripheral Blood Demand Share, 2019-2026
13. Middle East & Africa Peripheral Blood Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Peripheral Blood Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Peripheral Blood Market Size and Volume Forecast by Application
13.4.1. Disease Treatment
13.4.2. Research and Development
13.4.3. Other
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Peripheral Blood Market Size and Volume Forecast by Type
13.7.1. Leukopak
13.7.2. Stem Cells
13.7.3. PBMCs
13.7.4. Others
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Peripheral Blood Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Peripheral Blood Market: Market Share Analysis
14.2. Peripheral Blood Distributors and Customers
14.3. Peripheral Blood Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. HemaCare
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. StemExpress
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. AllCells
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Mozobil
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. COMPANY5
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. COMPANY6
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. COMPANY7
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. COMPANY8
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. COMPANY9
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. COMPANY 10
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. COMPANY 11
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook